Ample Organics Brings Izenda's Embedded
Self-Service BI and Analytics Platform to Licensed #Marijuana Industry
ATLANTA - April 12, 2017 (Investorideas.com Newswire) Izenda, a
provider of a business intelligence (BI) and analytics platform purpose-built
for OEM use and embedding, today announced an integration partnership with
Ample Organics—the most widely adopted enterprise seed-to-sale platform in
Canada.
Architected for compliance with Health Canada's Access to
Cannabis for Medical Purposes Regulations, (ACMPR), Ample Organics is the
enterprise software solution driving compliance at some of the world's largest
and most sophisticated marijuana companies. Often referred to as ‘Seed-to-Sale'
or ‘Track-and-Trace' software, Ample Organics is the infrastructure of the
Canadian marijuana industry and serves as the system of record for controlled
inventory at every stage of the manufacturing and fulfillment process in over
60 percent of licensed Canadian medical marijuana producers. Over 75,000 of the
120,000 medical marijuana patients across Canada are registered on the Ample
Organics platform.
"We already operate in the most sophisticated medical
marijuana market in the world and we're about to legalize," said John X.
Prentice, president and CEO of Ample Organics. "Beyond the advantages
business intelligence brings to our customers, we have the opportunity to
leverage these massive datasets to better understand cannabis both as a
medicine and as a business. What we will learn, and what Izenda enables our
customers to learn, will shape the cannabis industry globally for years to
come."
According to Scott Walters, CEO of MoreEtc, "John and his
team continue to deliver outstanding integration and workflow efficiency across
multiple regulated cannabis business environments in North America. As we
develop new medical products and work with licensed growers, the ability to use
Ample's operating system, risk management tools, and analytics for genetics
gives us a unique advantage in finding revenue opportunities."
Ample Organics operates an extensive feature set built into a
robust end-to-end tracking and reporting system. Izenda enables Ample Organics
customers to easily analyze thousands of data points collected for improved
quality assurance, operational efficiency, compliance, and generalized
reporting. Many legacy reports will be migrated and offered in new interactive
formats. Izenda's new easy-to-use interface will empower end-users to make
data-driven decisions that will increase production capacity, better serve
patients, and deeply analyze market trends.
About
Ample Organics
Ample Organics is the most widely adopted seed-to-sale software
solution among Canada's licensed medical marijuana producers, designed
specifically for compliance with Health Canada's Access to Cannabis for Medical
Purposes Regulations, or ACMPR.
About
lzenda
Izenda offers an embedded self-service business intelligence
(BI) and analytics platform purpose built for software companies, solutions
providers and their customers. Izenda integrates seamlessly in applications to
deliver BI and analytics directly to the people who need it most – application
end users who want to easily analyze, visualize, and share valuable data and
insights in real time.
Based in Atlanta, Ga. and founded in 2007, Izenda is used by
more than 10,000 organizations on a daily basis. https://www.Izenda.com.
CONTACT:
Lauren Curley
(617) 529-6463
lauren@straight-linepr.com
(617) 529-6463
lauren@straight-linepr.com
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
License to Grow is one that will complete the entire process how many plants can you grow with a medical card in canada. So, contact us acquiring a licence and we’ll help you through the process every step of the way.
ReplyDelete